Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Vascular

Explore clinical trials studying Skin Diseases, Vascular. Study availability and eligibility vary by location and protocol.

953 public trials 192 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Vascular trial results

Completed

A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria

NCT02392624

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
Locations
  • Allergy and Asthma Relief Experts Granada Hills, California, United States
  • Allergy & Asthma Care Center of Southern California Long Beach, California, United States
  • Dermatology Research Associate Los Angeles, California, United States
  • Southern California Research Center Mission Viejo, California, United States
View all 40 locations
View Trial Details
Completed

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

NCT00556439

Conditions
Aortic Arch Syndromes, Aortic Diseases, Arteritis, +17 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Johns Hopkins Medical Center Baltimore, Maryland, United States
  • Boston University Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

AWARE - Chronic Urticaria

NCT02435238

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
Locations
  • Novartis Investigative Site Plymouth, Devon, United Kingdom
  • Novartis Investigative Site Darlington, Durham, United Kingdom
  • Novartis Investigative Site Leytonstone, London, United Kingdom
  • Novartis Investigative Site Salford, Manchester, United Kingdom
View all 21 locations
View Trial Details
Completed

A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis

NCT02020889

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +12 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Bethesda, Maryland, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

NCT02247739

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • University of South Florida Asthma, Allergy and Immunology Clinical Research Unit Tampa, Florida, United States
  • University of South Florida, Asthma, Allergy & Immunology Clinical Research Unit Tampa, Florida, United States
  • Washington University Division of Allergy and Immunology St Louis, Missouri, United States
  • Baker Allergy, Asthma and Dermatology Research Center Lake Oswego, Oregon, United States
View Trial Details

Related conditions